Please contact us for more information or to learn if you are eligible to participate.
Purpose is to determine if “MEDI8897” will prevent medically attended Respiratory syncytial virus (RSV) in healthy infants entering their first RSV season.
Principal Investigator | Dynio Honrubia, MD |
Co-PI | Luis Cantu Jr. |
Sponsor | MedImmune, LLC |
Type of Trial | Interventional |